Data

REDUCE: Does Antipsychotic Dose Reduction Lead to Better Functional Recovery in First Episode Psychosis: A Randomised Controlled Trial

Health Data Australia Contributor Records
Killackey, Eoin ; Mental Health Node
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.26187/VC6S-S708&rft.title=REDUCE: Does Antipsychotic Dose Reduction Lead to Better Functional Recovery in First Episode Psychosis: A Randomised Controlled Trial&rft.identifier=http://doi.org/10.26187/VC6S-S708&rft.publisher=Orygen&rft.description=This dataset pertains to a randomized controlled trial investigating whether reduced antipsychotic dosage combined with Evidence-Based Intensive Recovery Treatment (EBIRT) leads to improved functioning in young people recovering from first episode psychosis (FEP). The trial includes two groups: one receiving a dose reduction strategy (DRS+) combined with EBIRT, and the other receiving antipsychotic maintenance treatment (AMTx+) along with EBIRT. Additionally, 40 healthy controls will be assessed for comparison across multiple time points. The study aims to assess clinical, cognitive, and physical health outcomes over a 15-18 month treatment period with follow-up at 24 months.&rft.creator=Killackey, Eoin &rft.creator=Mental Health Node &rft.date=2024&rft.relation=www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12617000870358&rft_subject=FOR: Mental Health&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Full description

This dataset pertains to a randomized controlled trial investigating whether reduced antipsychotic dosage combined with Evidence-Based Intensive Recovery Treatment (EBIRT) leads to improved functioning in young people recovering from first episode psychosis (FEP). The trial includes two groups: one receiving a dose reduction strategy (DRS+) combined with EBIRT, and the other receiving antipsychotic maintenance treatment (AMTx+) along with EBIRT. Additionally, 40 healthy controls will be assessed for comparison across multiple time points. The study aims to assess clinical, cognitive, and physical health outcomes over a 15-18 month treatment period with follow-up at 24 months.

Notes

HeSANDA 1.0.0

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

  • References Does Antipsychotic Dose Reduction in combination with Evidence-Based Intensive Recovery Treatment (EBIRT) Lead to Better Functional Recovery in First Episode Psychosis: A Randomised Controlled Trial
    local : www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12617000870358

Related People

Subjects
FOR: Mental Health |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers